Monday, February 4, 2013 Saturday, February 2, 2013 Friday, February 1, 2013- 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Fri, Feb 1)
- CELSION CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Fri, Feb 1)
- Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year HighMarketwired (Fri, Feb 1)
- Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Fri, Feb 1)
- Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sareptaat TheStreet (Fri, Feb 1)
Thursday, January 31, 2013- Celsion's 'Bad Beat' : 4 'Tells' That Longs Missedat Seeking Alpha (Thu, Jan 31)
- Why Celsion Shares Were Evisceratedat Motley Fool (Thu, Jan 31)
- Celsion Phase III Failure: What Went Wrong?at Seeking Alpha (Thu, Jan 31)
- Why Shares of Celsion Got Crushed Todayat Motley Fool (Thu, Jan 31)
- Celsion Shares Nosedive After Cancer Therapy Failsat Minyanville (Thu, Jan 31)
- Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against Celsion CorporationBusiness Wire (Thu, Jan 31)
- Can Celsion Survive After Imploding Over Phase III Results?at Seeking Alpha (Thu, Jan 31)
- Celsion Collapses on Failure: What's Next?at Motley Fool (Thu, Jan 31)
- CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements anEDGAR Online (Thu, Jan 31)
- Celsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver CancerPR Newswire (Thu, Jan 31)
Wednesday, January 30, 2013 Tuesday, January 29, 2013 Monday, January 28, 2013 Sunday, January 27, 2013Add CLSN News to My Yahoo!  | |
|